{"resourceType":"ValueSet","id":"2.16.840.1.113883.17.4077.2.1006","meta":{"versionId":"16","lastUpdated":"2020-06-25T13:18:56.000-04:00"},"text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\">\n      <h2>Coagulopathies</h2>\n      <p>This value set includes codes from the following code systems:</p>\n      <ul>\n        <li>Include these codes as defined in \n          <code>http://hl7.org/fhir/sid/icd-9-cm</code>\n          <table class=\"none\">\n            <tr>\n              <td>\n                <b>Code</b>\n              </td>\n              <td>\n                <b>Display</b>\n              </td>\n            </tr>\n            <tr>\n              <td>286.0</td>\n              <td>Congenital factor VIII disorder</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>286.1</td>\n              <td>Congenital factor IX disorder</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>286.2</td>\n              <td>Congenital factor XI deficiency</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>286.3</td>\n              <td>Congenital deficiency of other clotting factors</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>286.4</td>\n              <td>Von Willebrand's disease</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>286.52</td>\n              <td>Acquired hemophilia</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>286.53</td>\n              <td>Antiphospholipid antibody with hemorrhagic disorder</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>286.59</td>\n              <td>Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>286.6</td>\n              <td>Defibrination syndrome</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>286.7</td>\n              <td>Acquired coagulation factor deficiency</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>286.9</td>\n              <td>Other and unspecified coagulation defects</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>287.30</td>\n              <td>Primary thrombocytopenia,unspecified</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>287.31</td>\n              <td>Immune thrombocytopenic purpura</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>287.32</td>\n              <td>Evans' syndrome</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>287.33</td>\n              <td>Congenital and hereditary thrombocytopenic purpura</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>287.39</td>\n              <td>Other primary thrombocytopenia</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>287.41</td>\n              <td>Posttransfusion purpura</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>287.49</td>\n              <td>Other secondary thrombocytopenia</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>287.5</td>\n              <td>Thrombocytopenia, unspecified</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>287.8</td>\n              <td>Other specified hemorrhagic conditions</td>\n              <td/>\n            </tr>\n            <tr>\n              <td>287.9</td>\n              <td>Unspecified hemorrhagic conditions</td>\n              <td/>\n            </tr>\n          </table>\n        </li>\n      </ul>\n    </div>"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.17.4077.2.1006","version":"20181127","name":"Coagulopathies","status":"active","date":"2018-11-27T01:00:04-05:00","publisher":"ACEP/AMA-PCPI Steward","compose":{"include":[{"system":"http://hl7.org/fhir/sid/icd-9-cm","concept":[{"code":"286.0","display":"Congenital factor VIII disorder"},{"code":"286.1","display":"Congenital factor IX disorder"},{"code":"286.2","display":"Congenital factor XI deficiency"},{"code":"286.3","display":"Congenital deficiency of other clotting factors"},{"code":"286.4","display":"Von Willebrand's disease"},{"code":"286.52","display":"Acquired hemophilia"},{"code":"286.53","display":"Antiphospholipid antibody with hemorrhagic disorder"},{"code":"286.59","display":"Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors"},{"code":"286.6","display":"Defibrination syndrome"},{"code":"286.7","display":"Acquired coagulation factor deficiency"},{"code":"286.9","display":"Other and unspecified coagulation defects"},{"code":"287.30","display":"Primary thrombocytopenia,unspecified"},{"code":"287.31","display":"Immune thrombocytopenic purpura"},{"code":"287.32","display":"Evans' syndrome"},{"code":"287.33","display":"Congenital and hereditary thrombocytopenic purpura"},{"code":"287.39","display":"Other primary thrombocytopenia"},{"code":"287.41","display":"Posttransfusion purpura"},{"code":"287.49","display":"Other secondary thrombocytopenia"},{"code":"287.5","display":"Thrombocytopenia, unspecified"},{"code":"287.8","display":"Other specified hemorrhagic conditions"},{"code":"287.9","display":"Unspecified hemorrhagic conditions"}]}]}}